Research ArticleBrief Communication
PSMA PET for the Assessment of Metastatic Hormone-Sensitive Prostate Cancer Volume of Disease
Francesco Barbato, Wolfgang P. Fendler, Isabel Rauscher, Ken Herrmann, Axel Wetter, Justin Ferdinandus, Robert Seifert, Michael Nader, Kambiz Rahbar, Boris Hadaschik, Matthias Eiber, Andrei Gafita and Manuel Weber
Journal of Nuclear Medicine December 2021, 62 (12) 1747-1750; DOI: https://doi.org/10.2967/jnumed.121.262120
Francesco Barbato
1Department of Nuclear Medicine, University of Duisburg–Essen and German Cancer Consortium–University Hospital Essen, Essen, Germany;
Wolfgang P. Fendler
1Department of Nuclear Medicine, University of Duisburg–Essen and German Cancer Consortium–University Hospital Essen, Essen, Germany;
Isabel Rauscher
2Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany;
Ken Herrmann
1Department of Nuclear Medicine, University of Duisburg–Essen and German Cancer Consortium–University Hospital Essen, Essen, Germany;
Axel Wetter
3Institute of Diagnostic and Interventional Radiology and Neuroradiology, University of Duisburg–Essen and German Cancer Consortium–University Hospital Essen, Essen, Germany;
Justin Ferdinandus
1Department of Nuclear Medicine, University of Duisburg–Essen and German Cancer Consortium–University Hospital Essen, Essen, Germany;
Robert Seifert
4University of Münster and Cancer Consortium–University Hospital Münster, Münster, Germany; and
Michael Nader
1Department of Nuclear Medicine, University of Duisburg–Essen and German Cancer Consortium–University Hospital Essen, Essen, Germany;
Kambiz Rahbar
4University of Münster and Cancer Consortium–University Hospital Münster, Münster, Germany; and
Boris Hadaschik
5Department of Urology, University of Duisburg–Essen and German Cancer Consortium–University Hospital Essen, Essen, Germany
Matthias Eiber
2Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany;
Andrei Gafita
2Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany;
Manuel Weber
1Department of Nuclear Medicine, University of Duisburg–Essen and German Cancer Consortium–University Hospital Essen, Essen, Germany;
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 62, Issue 12
December 1, 2021
PSMA PET for the Assessment of Metastatic Hormone-Sensitive Prostate Cancer Volume of Disease
Francesco Barbato, Wolfgang P. Fendler, Isabel Rauscher, Ken Herrmann, Axel Wetter, Justin Ferdinandus, Robert Seifert, Michael Nader, Kambiz Rahbar, Boris Hadaschik, Matthias Eiber, Andrei Gafita, Manuel Weber
Journal of Nuclear Medicine Dec 2021, 62 (12) 1747-1750; DOI: 10.2967/jnumed.121.262120
PSMA PET for the Assessment of Metastatic Hormone-Sensitive Prostate Cancer Volume of Disease
Francesco Barbato, Wolfgang P. Fendler, Isabel Rauscher, Ken Herrmann, Axel Wetter, Justin Ferdinandus, Robert Seifert, Michael Nader, Kambiz Rahbar, Boris Hadaschik, Matthias Eiber, Andrei Gafita, Manuel Weber
Journal of Nuclear Medicine Dec 2021, 62 (12) 1747-1750; DOI: 10.2967/jnumed.121.262120